News
The market for brain health supplements has long been seen as two markets, each with specific goals and concerns, one fueled by aspiration and the other by desperation, but new data from Nutrition Business Journal suggests the twin drivers of brain health sales might be meeting in the middle.
Or they may at least be meeting in the mainstream, according to new data from the Condition Specific Report, the latest report published by Nutrition Business Journal (NBJ). This makes brain health a bright spot for the US supplement industry. NBJ tracked 7.2% growth for brain health in 2022, a year when the overall industry grew at just 1.9%.

Mainstreaming, the report contends, helps explain that growth.
Mention cognitive health to most people and they might think of commercials for Prevagen and the like, all featuring older consumers telling stories of failing memory followed by a lite version of the science. As one supplement industry insider jokes, “Four out of five jellyfish recommend Prevagen.”
But another slice of the market, younger and with ambitions of boosting their brain power rather than just hanging onto it is also a factor in cognitive health. It might be these consumers, only recently emerging from neurohacker chat rooms, who are helping move the concept closer to the mainstream where brands can court consumers not driven by the fear of memory loss and decline.
It’s difficult to tease out exactly how much of the growth for the condition category is coming from consumers chasing better mental performance and not fleeing decline, but NBJ is seeing brands marketing performance exhibiting strong growth. One of them, Neurhoacker Collective, is claiming 30% growth year over year.
Growth for the brain health category easily outpaced US sales growth for supplements marketed to conditions like sleep and heart health. Much of the brain health action is also happening online, with gains for the direct-to-consumer channels hitting double digits for the last three years. That could be another sign that younger consumers seeking a mental edge are expanding the market.
Brain health is just one of 19 condition markets covered in the 20-chapter report. Interesting developments are also being seen in weight management, menopause, and children’s health. The report provides a deep drive into not just what consumers are buying but why they are buying it.
11 Mar 2026
The EU's olive oil market is highly regulated to ensure quality, safety, and traceability – but a recent audit found control system gaps that need improving.
Read more
9 Mar 2026
Mondelēz International will need to make successful products with plant-based ingredients if it is to meet its long-term climate commitments, it says.
Read more
5 Mar 2026
British retailer Marks and Spencer has introduced 12 new products to its 'Only … Ingredients' range, as brands are advised to focus on “transparent communication”.
Read more
4 Mar 2026
Innovative sustainable animal products and plant-based alternatives can plug health and environmental concerns – but consumer willingness to pay for these products remains variable, finds an EU-funded study.
Read more
2 Mar 2026
Lidl is “setting the pace” in Europe's transition towards sustainable food systems. How did other European supermarkets score, according to Superlist Environment Europe 2026?
Read more
27 Feb 2026
For healthy indulgent products, messaging around enjoyment resonates more strongly than “guilt-free”, according to a study by EIT Food.
Read more
26 Feb 2026
The European Commission will tighten controls on food and feed imports and may extend France's ban on products containing prohibited pesticides.
Read more
25 Feb 2026
Dogs fed on premium, meat-rich pet food can have bigger dietary carbon footprints than their owners – but using by-products is a “highly relevant” solution for brands.
Read more
24 Feb 2026
Herbs, spices, and white powders are highly at risk of food fraud – but the industry is embracing food fingerprinting coupled with artificial intelligence to fight it.
Read more
23 Feb 2026
Successful GLP-1 friendly products will be the ones that feel inclusive – not those that turn the product into a medical badge, says a Rabobank analyst.
Read more